Cargando…
Clinical Validation of a Serum Protein Panel (FLNA, FLNB and KRT19) for Diagnosis of Prostate Cancer
This study reports on the development of a novel serum protein panel of three prostate cancer biomarkers, Filamin A, Filamin B and Keratin-19 (FLNA, FLNB and KRT19) using multivariate models for disease screening and prognosis. ELISA and IPMRM (LC-MS/MS) based assays were developed and analytically...
Autores principales: | Ravipaty, Shobha, Wu, Wenfang, Dalvi, Aditee, Tanna, Nikunj, Andreazi, Joe, Friss, Tracey, Klotz, Allison, Liao, Chenchen, Garren, Jeonifer, Schofield, Sally, Diamandis, Eleftherios P, Klein, Eric A, Dobi, Albert, Srivastava, Shiv, Tekumalla, Poornima, Kiebish, Michael A, Vishnudas, Vivek, Sarangarajan, Ranga Prasad, Narain, Niven R, Akmaev, Viatcheslav R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909981/ https://www.ncbi.nlm.nih.gov/pubmed/29682400 http://dx.doi.org/10.4172/2155-9929.1000323 |
Ejemplares similares
-
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
por: Kiebish, Michael A., et al.
Publicado: (2021) -
Identification of Filamin-A and -B as potential biomarkers for prostate cancer
por: Narain, Niven R, et al.
Publicado: (2016) -
Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis
por: Mishra, Prachi, et al.
Publicado: (2019) -
Upregulation of circFLNA contributes to laryngeal squamous cell carcinoma migration by circFLNA–miR-486-3p-FLNA axis
por: Wang, Jian-Xing, et al.
Publicado: (2019) -
Integrated Metabolomics Assessment of Human Dried Blood Spots and Urine Strips
por: Drolet, Jeremy, et al.
Publicado: (2017)